Schmidt O, Weyer Y, Baumann V, Widerin M, Eising S, Angelova M, et al. Endosome and Golgi-associated degradation (EGAD) of membrane proteins regulates sphingolipid metabolism. EMBO J. 2019;38:e101433 pubmed publisher

Mensah E, Guo X, Gao X, Fujita M. Establishment of DHFR-deficient HEK293 cells for high yield of therapeutic glycoproteins. J Biosci Bioeng. 2019;: pubmed publisher

Hajian B, Scocchera E, Shoen C, Krucinska J, Viswanathan K, G Dayanandan N, et al. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents. Cell Chem Biol. 2019;26:781-791.e6 pubmed publisher

Albrecht L, Bui M, De Robertis E. Canonical Wnt is inhibited by targeting one-carbon metabolism through methotrexate or methionine deprivation. Proc Natl Acad Sci U S A. 2019;116:2987-2995 pubmed publisher

Sachs N, Papaspyropoulos A, Zomer van Ommen D, Heo I, Böttinger L, Klay D, et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 2019;38: pubmed publisher

Alata Jimenez N, Torres Pérez S, Sánchez Vásquez E, Fernandino J, Strobl Mazzulla P. Folate deficiency prevents neural crest fate by disturbing the epigenetic Sox2 repression on the dorsal neural tube. Dev Biol. 2018;444 Suppl 1:S193-S201 pubmed publisher

Tanimoto A, Shinozaki Y, Nozawa K, Kimoto Y, Amano W, Matsuo A, et al. Improvement of spontaneous locomotor activity with JAK inhibition by JTE-052 in rat adjuvant-induced arthritis. BMC Musculoskelet Disord. 2015;16:339 pubmed publisher

Salva K, Wood G. Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma. Photochem Photobiol. 2015;91:1444-51 pubmed publisher

Chen X, Hansen D, Merry G, DeJarnette C, Nolen G, Sloper D, et al. Developing osteoblasts as an endpoint for the mouse embryonic stem cell test. Reprod Toxicol. 2015;53:131-40 pubmed publisher

Emery P, Hammoudeh M, Combe B. Etanercept tapering in rheumatoid arthritis. N Engl J Med. 2015;372:489-90 pubmed publisher

Patel S, Kusano A, Truong A, Stelzer K, Laramore G. Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma. Am J Clin Oncol. 2015;38:47-50 pubmed publisher

Liu X, Kuriyan A, Amescua G. A painful red eye. JAMA Ophthalmol. 2015;133:95-6 pubmed publisher

Trendowski M, Wong V, Yu G, Fondy T. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. Anticancer Res. 2015;35:65-76 pubmed

Panther D, Nino T, Macknet K, Macknet C. Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate. Dermatol Surg. 2015;41:172-5 pubmed publisher

Ieva R, Schrempp S, Opaliński L, Wollweber F, Höß P, Heißwolf A, et al. Mgr2 functions as lateral gatekeeper for preprotein sorting in the mitochondrial inner membrane. Mol Cell. 2014;56:641-52 pubmed publisher

Nowak D, Liem N, Mossner M, Klaumünzer M, Papa R, Nowak V, et al. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance. Exp Hematol. 2015;43:32-43.e1-35 pubmed publisher

Sarker S, Kodali S, Weber F. A new meaning to butterflies in the stomach. Gastroenterology. 2015;148:e12-3 pubmed publisher

Keystone E, Taylor P, Drescher E, Schlichting D, Beattie S, Berclaz P, et al. Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate. Ann Rheum Dis. 2015;74:333-40 pubmed publisher

Polcari I, Moon A, Mathes E, Gilmore E, Paller A. Headaches as a presenting symptom of linear morphea en coup de sabre. Pediatrics. 2014;134:e1715-9 pubmed publisher

Tanimoto A, Ogawa Y, Oki C, Kimoto Y, Nozawa K, Amano W, et al. Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo. Inflamm Res. 2015;64:41-51 pubmed publisher

Emery P, Hammoudeh M, Fitzgerald O, Combe B, Martin Mola E, Buch M, et al. Sustained remission with etanercept tapering in early rheumatoid arthritis. N Engl J Med. 2014;371:1781-92 pubmed publisher

Kadia T, Kantarjian H, Thomas D, O Brien S, Estrov Z, Ravandi F, et al. Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia. Am J Hematol. 2015;90:120-4 pubmed publisher

Emery P, Burmester G, Bykerk V, Combe B, Furst D, Barré E, et al. Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24?months, with a 12-month, double-blind treatment period. Ann Rheum Dis. 2015;74:19-26 pubmed publisher

Hoelzer D, Walewski J, Dohner H, Viardot A, Hiddemann W, Spiekermann K, et al. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood. 2014;124:3870-9 pubmed publisher

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, et al. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Ann Rheum Dis. 2015;74:27-34 pubmed publisher

Hamilton B, Rybicki L, Dean R, Majhail N, Haddad H, Abounader D, et al. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation. Am J Hematol. 2015;90:144-8 pubmed publisher

Levinsen M, Rosthøj S, Nygaard U, Heldrup J, Harila Saari A, Jonsson O, et al. Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity. Cancer Chemother Pharmacol. 2015;75:59-66 pubmed publisher

Wright K, Panetta J, Onar Thomas A, Reddick W, Patay Z, Qaddoumi I, et al. Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemother Pharmacol. 2015;75:27-35 pubmed publisher

Tuure L, Hämäläinen M, Moilanen T, Moilanen E. Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes. Scand J Rheumatol. 2015;44:74-9 pubmed publisher

Vrhovac I, Balen Eror D, Klessen D, Burger C, Breljak D, Kraus O, et al. Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart. Pflugers Arch. 2015;467:1881-98 pubmed publisher

Levin I, Cohen A, Almog B. Reply: To PMID 24657132. Am J Obstet Gynecol. 2015;212:122 pubmed publisher

Sholapurkar S. Methotrexate for ectopic pregnancy: success rates and avoidance of embryopathy. Am J Obstet Gynecol. 2015;212:121-2 pubmed publisher

Takeshita J, Wang S, Shin D, Callis Duffin K, Krueger G, Kalb R, et al. Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. J Am Acad Dermatol. 2014;71:1167-75 pubmed publisher

Cohen A, Bibi G, Almog B, Tsafrir Z, Levin I. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin. Fertil Steril. 2014;102:1646-9 pubmed publisher

Perinelli D, Bonacucina G, Pucciarelli S, Cespi M, Casettari L, Polzonetti V, et al. Could albumin affect the self-assembling properties of a block co-polymer system and drug release? An in-vitro study. Pharm Res. 2015;32:1094-104 pubmed publisher

Weinblatt M, Genovese M, Ho M, Hollis S, Rosiak Jedrychowicz K, Kavanaugh A, et al. Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheumatol. 2014;66:3255-64 pubmed publisher

Jin H, Cho H, Kim W, Mun J, Song M, Kim H, et al. Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept. J Am Acad Dermatol. 2014;71:e152-3 pubmed publisher

Abdel M, Figgie M. Surgical management of the juvenile idiopathic arthritis patient with multiple joint involvement. Orthop Clin North Am. 2014;45:435-42 pubmed publisher

Georgiou K, Nadhanan R, Fan C, Xian C. Methotrexate-induced bone marrow adiposity is mitigated by folinic acid supplementation through the regulation of Wnt/β-catenin signalling. J Cell Physiol. 2015;230:648-56 pubmed publisher

Funk R, van Haandel L, Leeder J, Becker M. Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate. Arthritis Rheumatol. 2014;66:3476-85 pubmed publisher

Oberoi S, Trehan A, Marwaha R. Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country. Pediatr Blood Cancer. 2014;61:2218-22 pubmed publisher

Ylinen E, Jahnukainen K, Saarinen Pihkala U, Jahnukainen T. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61:2199-202 pubmed publisher

Huizinga T, Conaghan P, Martin Mola E, Schett G, Amital H, Xavier R, et al. Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study. Ann Rheum Dis. 2015;74:35-43 pubmed publisher

Chande N, Wang Y, Macdonald J, McDonald J. Methotrexate for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2014;:CD006618 pubmed publisher

Patel V, Wang Y, Macdonald J, McDonald J, Chande N. Methotrexate for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2014;:CD006884 pubmed publisher

Alexander S, Kraveka J, Weitzman S, Lowe E, Smith L, Lynch J, et al. Advanced stage anaplastic large cell lymphoma in children and adolescents: results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: a report from the children's oncology group. Pediatr Blood Cancer. 2014;61:2236-42 pubmed publisher

Zhang H, He X, Wang C, Wang Y, Chen Y, Li J, et al. Impact of SLCO1B1 521T > C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate. Pediatr Blood Cancer. 2014;61:2203-7 pubmed publisher

Byrne S, Lim M. N-methyl-D-aspartate receptor antibody encephalitis: how much treatment is enough?. Dev Med Child Neurol. 2015;57:14-5 pubmed publisher

McDonald J, Wang Y, Tsoulis D, Macdonald J, Feagan B. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev. 2014;:CD003459 pubmed publisher

McLaren J, Barnhart K, Sammel M, Appleby D, Butts S. Success of the two-dose methotrexate protocol for treatment of ectopic pregnancy in women with a history of prior ectopic pregnancy. J Reprod Med. 2014;59:379-84 pubmed

Balar A, Milowsky M. Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?. Cancer. 2015;121:179-87 pubmed publisher

Kim S, Park S, Kang E, Choi J, Lim D, Ko Y, et al. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients. Ann Hematol. 2015;94:71-8 pubmed publisher

Castellino S, Ullrich N, Whelen M, Lange B. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors. J Natl Cancer Inst. 2014;106: pubmed publisher

Rytting M, Thomas D, O Brien S, Ravandi Kashani F, Jabbour E, Franklin A, et al. Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL). Cancer. 2014;120:3660-8 pubmed publisher

Zgheib N, Akra Ismail M, Aridi C, Mahfouz R, Abboud M, Solh H, et al. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2014;24:387-96 pubmed publisher

Humme D, Nast A, Erdmann R, Vandersee S, Beyer M. Systematic review of combination therapies for mycosis fungoides. Cancer Treat Rev. 2014;40:927-33 pubmed publisher

Symmonds M, Kuker W, Schulz U. Clinical reasoning: progressive visuospatial problems in a 71-year-old man. Neurology. 2014;83:e6-10 pubmed publisher

Necessary C, Roffwarg D, ELLIS D. Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma. J Am Acad Dermatol. 2014;71:e23-4 pubmed publisher

Ram R, Herscovici C, Dahan D, Israeli M, Dreyer J, Peck A, et al. Tailoring the GVHD prophylaxis regimen according to transplantation associated toxicities-Substituting the 3rd dose of methotrexate to mycophenolate mofetil. Leuk Res. 2014;38:913-7 pubmed publisher

Schmiegelow K, Nielsen S, Frandsen T, Nersting J. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction. J Pediatr Hematol Oncol. 2014;36:503-17 pubmed publisher

Holdhoff M, Ambady P, Abdelaziz A, Sarai G, Bonekamp D, Blakeley J, et al. High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma. Neurology. 2014;83:235-9 pubmed publisher

Vora A, Goulden N, Mitchell C, Hancock J, Hough R, Rowntree C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014;15:809-18 pubmed publisher

Rathinam S, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, et al. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121:1863-70 pubmed publisher

Burmester G, Kivitz A, Kupper H, Arulmani U, Florentinus S, Goss S, et al. Response to H Zeidler's comments on the CONCERTO study. Ann Rheum Dis. 2014;73:e51 pubmed publisher

Zou B, Han Z, Wang Z, Bian J, Xu J, Wang H, et al. Neoadjuvant therapy combined with a BMP regimen for treating penile cancer patients with lymph node metastasis: a retrospective study in China. J Cancer Res Clin Oncol. 2014;140:1733-8 pubmed publisher

Rashidi A, Maherus E. After the treated mole. Blood. 2014;123:2757 pubmed

Heath J, Burgett S, Gaca A, Jaffe R, Wechsler D. Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy. Pediatr Blood Cancer. 2014;61:1874-6 pubmed publisher

Jordan J, Plotkin S, Dietrich J. Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 2014;71:918-9 pubmed publisher

Sidbury R, Davis D, Cohen D, Cordoro K, Berger T, Bergman J, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71:327-49 pubmed publisher

Hentrich M, Hoffmann C, Mosthaf F, Muller M, Siehl J, Wyen C, et al. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). Ann Hematol. 2014;93:913-21 pubmed publisher

Koens L, Senff N, Vermeer M, Willemze R, Jansen P. Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: A clinicopathologic and immunophenotypical study of 10 cases. Am J Surg Pathol. 2014;38:999-1006 pubmed publisher

Schoffelen T, Kampschreur L, van Roeden S, Wever P, den Broeder A, Nabuurs Franssen M, et al. Coxiella burnetii infection (Q fever) in rheumatoid arthritis patients with and without anti-TNF? therapy. Ann Rheum Dis. 2014;73:1436-8 pubmed publisher

Sun N, Galvin J, Cooper K. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate. JAMA Dermatol. 2014;150:787-8 pubmed publisher

de Jong P, Hazes J, Han H, Huisman M, Van Zeben D, van der Lubbe P, et al. Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial. Ann Rheum Dis. 2014;73:1331-9 pubmed publisher

Puttevils D, De Vusser P, Geusens P, Dens J. Increased cardiovascular risk in patients with rheumatoid arthritis: an overview. Acta Cardiol. 2014;69:111-8 pubmed

Zeidler H. The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?. Ann Rheum Dis. 2014;73:e50 pubmed publisher

Conway R, Low C, Coughlan R, O Donnell M, Carey J. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheumatol. 2014;66:803-12 pubmed publisher

Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, et al. Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients. Mol Cancer Ther. 2014;13:1777-1790 pubmed publisher

Fushimi K, Tanabe N, Takami M. [A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adjuvant chemotherapy in patients with node-negative, triple-negative breast cancer]. Gan To Kagaku Ryoho. 2014;41:449-53 pubmed

Bohelay G, Bouaziz J, Nunes H, Rybojad M, Bagot M, Petit A, et al. Striking leflunomide efficacy against refractory cutaneous sarcoidosis. J Am Acad Dermatol. 2014;70:e111-3 pubmed publisher

Schiff M, Jaffe J, Freundlich B. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration. Ann Rheum Dis. 2014;73:1549-51 pubmed publisher

Soldini D, Gaspert A, Montani M, Reineke T, Rogler G, Odze R, et al. Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists. J Clin Pathol. 2014;67:582-6 pubmed publisher

El Mesallamy H, Rashed W, Hamdy N, Hamdy N. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?. J Cancer Res Clin Oncol. 2014;140:1359-65 pubmed publisher

Borradori L, Joly P. Toward a practical renaming of bullous pemphigoid and all its variants: cutaneous pemphigoid. JAMA Dermatol. 2014;150:459 pubmed publisher

de Rotte M, de Jong P, den Boer E, Pluijm S, Özcan B, Weel A, et al. Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis. Arthritis Rheumatol. 2014;66:2026-36 pubmed publisher

. In brief: otrexup--a single-use auto-injector formulation of methotrexate. Med Lett Drugs Ther. 2014;56:28 pubmed

Yamakawa T, Kurosawa M, Yonezumi M, Suzuki S, Suzuki H. [Methotrexate-related lymphomatoid granulomatosis successfully treated with discontinuation of methotrexate and radiotherapy to brain]. Rinsho Ketsueki. 2014;55:321-6 pubmed

Kenney L, Duffey Lind E, Ebb D, Sklar C, Grier H, Diller L. Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature. J Pediatr Hematol Oncol. 2014;36:237-40 pubmed publisher

Ferreri A, Ciceri F, Brandes A, Montanari M, Balzarotti M, Spina M, et al. MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years. Neurology. 2014;82:1370-3 pubmed publisher

Yang Z, Zhao W, Liu W, Lv Q, Dong X. Efficacy evaluation of methotrexate in the treatment of ankylosing spondylitis using meta-analysis. Int J Clin Pharmacol Ther. 2014;52:346-51 pubmed publisher

Lossos C, Bayraktar S, Weinzierl E, Younes S, Hosein P, Tibshirani R, et al. LMO2 and BCL6 are associated with improved survival in primary central nervous system lymphoma. Br J Haematol. 2014;165:640-8 pubmed publisher

Kojima Y, Hagiwara S, Uehira T, Ajisawa A, Kitanaka A, Tanuma J, et al. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan. Jpn J Clin Oncol. 2014;44:318-23 pubmed publisher

Boots C, Gustofson R, Feinberg E. Reply of the authors. Fertil Steril. 2014;101:e24 pubmed publisher

Xiao C, Dahan M. The effect of methotrexate injection for treatment of an ectopic pregnancy on ovarian reserve. Fertil Steril. 2014;101:e23 pubmed publisher

Coutre S, Othus M, Powell B, Willman C, Stock W, Paietta E, et al. Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy. Br J Haematol. 2014;165:497-503 pubmed publisher

Conaghan P, Peterfy C, Olech E, Kaine J, Ridley D, Dicarlo J, et al. The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy. Ann Rheum Dis. 2014;73:810-6 pubmed publisher

Ziółkowska H, Kisiel A, Leszczynska B, Bilska K, Jankowska K, Kuźma Mroczkowska E, et al. Continuous veno-venous hemodiafiltration in methotrexate intoxication. Med Wieku Rozwoj. 2013;17:347-54 pubmed

Plascencia Gomez A, Calderón Rocher C, Proy Trujillo H, Moreno Coutiño G. Neoadjuvant intralesional methotrexate before surgery in squamous cell carcinoma. Dermatol Surg. 2014;40:584-6 pubmed publisher

Perez Martín L, De Leon Luis J, Gámez Alderete F, Bravo C, Perez F, Aguaron A, et al. [Laparoscopic management of a spontaneous live monochorionic monoamniotic twin tubal ectopic pregnancy. A case report]. Ginecol Obstet Mex. 2013;81:612-5 pubmed

Dougados M, Kissel K, Conaghan P, Mola E, Schett G, Gerli R, et al. Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study. Ann Rheum Dis. 2014;73:803-9 pubmed publisher

Sadasivam N, Johnson R, Owen R. Resolution of methotrexate-induced Epstein-Barr virus-associated mucocutaneous ulcer. Br J Haematol. 2014;165:584 pubmed publisher

Kume K, Amano K, Yamada S, Kanazawa T, Ohta H, Hatta K, et al. The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis. Rheumatology (Oxford). 2014;53:900-3 pubmed publisher

Yamanaka H, Ishiguro N, Takeuchi T, Miyasaka N, Mukai M, Matsubara T, et al. Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial. Rheumatology (Oxford). 2014;53:904-13 pubmed publisher

Ram R, Yeshurun M, Vidal L, Shpilberg O, Gafter Gvili A. Mycophenolate mofetil vs. methotrexate for the prevention of graft-versus-host-disease--systematic review and meta-analysis. Leuk Res. 2014;38:352-60 pubmed publisher

Melachuri S, Gandrud L, Bostrom B. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61:1003-6 pubmed publisher

Lee M, Lin R, Lai M. Increased risk of diabetes mellitus in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. J Am Acad Dermatol. 2014;70:691-698 pubmed publisher

Cao X, Li J, Zhang W, Duan M, Shen T, Zhou D. Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse. Ann Hematol. 2014;93:1001-5 pubmed publisher

Ota H, Koyama N, Nakamura A, Matsuda M, Yamamoto Y, Tomoda K, et al. [Case report; a case of methotrexate-associated lymphoproliferative disorders caused with multiple lung nodules]. Nihon Naika Gakkai Zasshi. 2013;102:2676-8 pubmed

Komagata Y. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome. Nihon Naika Gakkai Zasshi. 2013;102:2639-44 pubmed

Kaneko J, Gozu K, Aoyagi H, Matsui T, Yoshida T, Hasegawa K, et al. [A case of iatrogenic immunodeficiency-associated lymphoproliferative disease in a patient treated with methotrexate for rheumatoid arthritis for 9 consecutive years, which Showed natural remission after discontinuation of MTX therapy]. Gan To Kagaku Ryoho. 2013;40:2454-6 pubmed

Fellows M, McDermott A, Clare K, Doherty A, Aardema M. The spectral karyotype of L5178Y TK⁺/⁻ mouse lymphoma cells clone 3.7.2C and factors affecting mutant frequency at the thymidine kinase (tk) locus in the microtitre mouse lymphoma assay. Environ Mol Mutagen. 2014;55:35-42 pubmed publisher

Perez Delboy A, Wright J. Surgical management of placenta accreta: to leave or remove the placenta?. BJOG. 2014;121:163-9; discussion 169-70 pubmed publisher

Fisher P. 50 years ago in the Journal of Pediatrics: central nervous system complications of children with acute leukemia: an evaluation of treatment methods. J Pediatr. 2014;164:33 pubmed publisher

Duffner P, ARMSTRONG F, Chen L, Helton K, Brecher M, Bell B, et al. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? . J Pediatr Hematol Oncol. 2014;36:8-15 pubmed publisher

Nwanyanwu K, Lim J. Smudge in my vision. JAMA Ophthalmol. 2013;131:1637-8 pubmed publisher

Shea B. Folic acid or folinic acid for reducing side effects of methotrexate for people with rheumatoid arthritis. J Evid Based Med. 2013;6:202-3 pubmed publisher

Vu Hoang P, Ambroise J, Dang Chi V, Dekairelle A, Dupont S, Huynh N, et al. Comparison of long-term outcome between white and Vietnamese children treated for acute lymphoblastic leukemia according to the FRALLE 2000 protocol. J Pediatr Hematol Oncol. 2014;36:534-40 pubmed publisher

Hashkes P, Becker M, Cabral D, Laxer R, Paller A, Rabinovich C, et al. Methotrexate: new uses for an old drug. J Pediatr. 2014;164:231-6 pubmed publisher

Tamilselvi E, Haripriya D, Hemamalini M, Pushpa G, Swapna S. Association of disease severity with IL-1 levels in methotrexate-treated psoriasis patients. Scand J Immunol. 2013;78:545-53 pubmed publisher

Dassopoulos T, Sultan S, Falck Ytter Y, Inadomi J, Hanauer S. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013;145:1464-78.e1-5 pubmed publisher

Terdiman J, Gruss C, Heidelbaugh J, Sultan S, Falck Ytter Y. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013;145:1459-63 pubmed publisher

Nagai Y, Minami T, Itami Y, Kobayashi Y, Shimizu N, Yamamoto Y, et al. [A case of a nonseminomatous germ cell tumor responding to MEA therapy]. Hinyokika Kiyo. 2013;59:693-7 pubmed

Naidu A, Kessler H, Pavelka M. Epstein-Barr virus-positive oral ulceration simulating Hodgkin lymphoma in a patient treated with methotrexate: case report and review of the literature. J Oral Maxillofac Surg. 2014;72:724-9 pubmed publisher

Sheen Y, Sheen Y, Sheu H, Sheen M. Bowen disease of the vulva successfully treated with intraarterial infusion chemotherapy. J Am Acad Dermatol. 2013;69:e305-6 pubmed publisher

Yazici Y, Bata Y. Parenteral methotrexate for the treatment of rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:46-8 pubmed

Mease P. Methotrexate in psoriatic arthritis. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S41-5 pubmed

Ruderman E. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S29-32 pubmed

Castrejón I, Gibson K, Pincus T. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S20-8 pubmed

Pincus T, Gibson K, Castrejón I. Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S9-19 pubmed

Chan E, Cronstein B. Mechanisms of action of methotrexate. Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S5-8 pubmed

Hugh J, Van Voorhees A, Nijhawan R, Bagel J, Lebwohl M, Blauvelt A, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014;70:168-77 pubmed publisher

Kirwan J, Boers M. Biological treatment in rheumatoid arthritis: when to stop?. Lancet. 2014;383:288-9 pubmed publisher

Smolen J, Emery P, Fleischmann R, van Vollenhoven R, Pavelka K, Durez P, et al. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet. 2014;383:321-32 pubmed publisher

de Rotte M, de Jong P, Pluijm S, Calasan M, Barendregt P, Van Zeben D, et al. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate. Arthritis Rheum. 2013;65:2803-13 pubmed publisher

Xu W, Zhang L, Chen X, Pan B, Mao J, Song H, et al. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies. Cancer Chemother Pharmacol. 2014;73:79-86 pubmed publisher

Tedeschi P, Markert E, Gounder M, Lin H, Dvorzhinski D, Dolfi S, et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis. 2013;4:e877 pubmed publisher

Chen S, Fahmi N, Bhattacharya C, Wang L, Jin Y, Benkovic S, et al. Fluorescent biphenyl derivatives of phenylalanine suitable for protein modification. Biochemistry. 2013;52:8580-9 pubmed publisher

Krüger K. [Rheumatoid arthritis: lower work loss during treatment with biologicals?--Modern treatment principles reduce work loss in rheumatoid arthritis]. Dtsch Med Wochenschr. 2013;138:2236 pubmed publisher

Saw V. Immunotherapy for corneal inflammatory disorders: stepping up and down the ladder. Br J Ophthalmol. 2013;97:1364-7 pubmed publisher

Verazza S, Negro G, Marafon D, Consolaro A, Martini A, Ravelli A. Possible discontinuation of therapies after clinical remission in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2013;31:S98-101; quiz S102-7 pubmed

Cohen I, Wolff J. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?. Pediatr Blood Cancer. 2014;61:7-10 pubmed publisher

Cohen I. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX). Med Hypotheses. 2013;81:942-7 pubmed publisher

Sumi T. [MTX associated lymphoproliferative disorder]. Nihon Jibiinkoka Gakkai Kaiho. 2013;116:734-5 pubmed

Niedzielska E, Wecławek Tompol J, Matkowska Kocjan A, Chybicka A. The influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexate. Adv Clin Exp Med. 2013;22:579-84 pubmed

Oberpichler Schwenk H. [Rheumatoid arthritis: what to do if methotrexate fails?]. Med Monatsschr Pharm. 2013;36:279 pubmed

Nejković L, Pazin V, Filimonovic D. Cesarean section scar pregnancy treatment--case report. Clin Exp Obstet Gynecol. 2013;40:304-6 pubmed

Gong W, Li X, Ren H, Han C, Li Y, Wu Z. Superselective uterine arterial embolization combined with transcatheter intra-arterial methotrexate infusion in 40 cases with fallopian tube ectopic pregnancy. Clin Exp Obstet Gynecol. 2013;40:222-6 pubmed

Horokhovs kyĭ I, Ieshchenko I, Bovt V, Ieshchenko V, Iurchuk I. [Functional state of the ileum, cationic peptids and zinc content in the Paneth cells of the rats following lincomycin, indomethacin and methotrexate andministration]. Fiziol Zh. 2013;59:78-88 pubmed

Hazra S, Choudhury A, Asaduzzaman A, Paul H. Adverse outcome of methotrexate and mini pulse betamethasone in the treatment of lichen planus. Bangladesh Med Res Counc Bull. 2013;39:22-7 pubmed

Bezborodova O, Nemtsova E, Venediktova I, Iakubovskaia R, Aleksandrova L, Kovalenko A. [Experimental study of remaxol as a drug for supportive therapy in traditional and high-dose treatment of tumors]. Eksp Klin Farmakol. 2013;76:18-22 pubmed

Aouinti I, Gaïes E, Trabelsi S, Salouage I, Jebabli N, Charfi R, et al. Delayed elimination of methotrexate in a patient receiving ciprofloxacin. Therapie. 2013;68:175-7 pubmed publisher

Solomon D, Curtis J, Saag K, Lii J, Chen L, Harrold L, et al. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs. Am J Med. 2013;126:730.e9-730.e17 pubmed publisher

Hershko H. [A case of a preventable death]. Harefuah. 2013;152:365-6 pubmed

Cremers J, Drent M, Bast A, Shigemitsu H, Baughman R, Valeyre D, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med. 2013;19:545-61 pubmed publisher

Weinblatt M. Methotrexate in rheumatoid arthritis: a quarter century of development. Trans Am Clin Climatol Assoc. 2013;124:16-25 pubmed

Katayama K, Nishino T, Takahashi Y, Tanaka T, Okitsu H, Okitsu N. [Approximately four years of survival benefits for a case of gastric cancer postoperative carcinomatous peritonitis by combined modality therapy]. Gan To Kagaku Ryoho. 2013;40:655-8 pubmed

Dogra S, Mahajan R. Systemic methotrexate therapy for psoriasis: past, present and future. Clin Exp Dermatol. 2013;38:573-88 pubmed publisher

. Fatal methotrexate overdose. Prescrire Int. 2013;22:126 pubmed

. Weekly oral methotrexate therapy: raise awareness of fatal dosing errors. Prescrire Int. 2013;22:126 pubmed

Kuleva S. [Delayed elimination of methotrexate after high-dose infusion]. Vopr Onkol. 2013;59:126-31 pubmed

Kalinina O, Kolotova E, Panfilova T, Shtil A, Frolov B. [The natural triterpenoid miliacin prevents methotrexate-induced oxidative stress and normalizes the expression of genes encoding the cytochrome P-450 2E1 isoform and glutathione reductase in the liver]. Patol Fiziol Eksp Ter. 2013;:70-4 pubmed

Sáez Ayala M, Montenegro M, Sánchez del Campo L, Fernández Pérez M, Chazarra S, Freter R, et al. Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell. 2013;24:105-19 pubmed publisher

Neuberg D, Arceci R. When "rare" is no excuse for progress. Blood. 2013;121:4970-2 pubmed publisher

McNeil C. Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants. J Natl Cancer Inst. 2013;105:922-3 pubmed publisher

. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis. BMJ. 2013;346:f3846 pubmed publisher

Kasai Yoshida E, Ogihara M, Ozawa M, Nozaki T, Morino M, Manabe A, et al. Temporal lobe epilepsy with hippocampal sclerosis in acute lymphoblastic leukemia. Pediatrics. 2013;132:e252-6 pubmed publisher

Marchetti M, Greer K. Pityriasis rubra pilaris treated with methotrexate resolving with an erythema gyratum repens-like appearance. J Am Acad Dermatol. 2013;69:e32-3 pubmed publisher

Sita Lumsden A, Medani H, Fisher R, Harvey R, Short D, Sebire N, et al. Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6. BJOG. 2013;120:1012-5 pubmed publisher

Bathon J, McMahon D. Making rational treatment decisions in rheumatoid arthritis when methotrexate fails. N Engl J Med. 2013;369:384-5 pubmed publisher

O Dell J, Mikuls T, Taylor T, Ahluwalia V, Brophy M, Warren S, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013;369:307-18 pubmed publisher

Hossain D. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients. Lepr Rev. 2013;84:105-12 pubmed

Ochi N, Yamane H, Yamagishi T, Monobe Y, Takigawa N. Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis. J Clin Oncol. 2013;31:e348-50 pubmed publisher

Waimann C, Marengo M, de Achaval S, Cox V, Garcia Gonzalez A, Reveille J, et al. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum. 2013;65:1421-9 pubmed publisher

Hung C, Wu B. Palmoplantar pustulosis presenting with chest pain. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. JAMA Dermatol. 2013;149:475-80 pubmed publisher

Gollard R, Selco S. Irreversible myelopathy associated with nelaribine in T-cell acute lymphoblastic leukemia. J Clin Oncol. 2013;31:e327-31 pubmed publisher

Gelfand J, Wang S, Takeshita J, Robertson A, Krueger G, Callis Duffin K, et al. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply. JAMA Dermatol. 2013;149:491 pubmed publisher

Davis S, Feldman S. Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol. 2013;149:490-1 pubmed publisher

Arcinue C, Hochberg F, Neumann R, Foster C. Diagnostic criteria for primary ocular lymphoma. Ophthalmology. 2013;120:646-646.e2 pubmed publisher

Burmester G, Benda B, Gruben D, Bradley J, Mebus C. Tofacitinib for rheumatoid arthritis - Authors' reply. Lancet. 2013;381:1812-3 pubmed publisher

Alba M, Flores Suarez L. Seven clinical conundrums in the treatment of ANCA-associated vasculitis. Clin Exp Rheumatol. 2013;31:S74-83 pubmed